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Dear Editor,
Selective mutism (SM) is a disorder characterized by inability 
to talk in specific situations, despite of being able to talk in 
familiar places. With a prevalence of 0.3%-1% in school-
age children,1,2 most cases (79%) start at preschool age and 
have transitory course.3,4 Psychotherapeutic interventions and 
selective serotonin reuptake inhibitors are considered first and 
second line treatments, respectively.1,5
We report a case of SM in a 17-year-old girl whose symptoms 
started when she was 4 years old and have persisted during 
adolescence. She stopped talking to everyone after a haircut. 
She panicked every time her mother went out or when she was 
left at school. She didn’t talk for 45 days, and then progressively 
recovered, talking first to her sisters, then to other relatives. 
One year later, she stopped talking again after her bike had 
been stolen. Three months later, she started to chat with relatives 
and two close friends. She hasn’t talked to anyone else since 
then. Despite this fact, she regularly goes to school and has 
friends of her age, with whom she communicates through e-mails 
and mimics. Neither academic nor cognitive impairment have 
been detected along all school years. She likes to dance and to 
play handball. When she needs something that requires talking, 
her mother does it on her behalf, which prevents her from being 
exposed and increases avoidance of anxiety situations. 
According to DSM-IV criteria, a diagnosis of SM was made. 
Assessed through a semi-structured interview (Schedule for 
affective disorders and schizophrenia for school-age children, 
K-SADS), she met diagnostic criteria for Separation Anxiety 
Disorder (in the past), current diagnosis of Specific Phobia. She 
didn’t have any other anxious (including social anxiety), affective 
or psychotic symptoms.
Before her referral, she was treated with psychodynamic 
therapy and took paroxetine (20 mg/daily) for 12 months without 
improvement. At our service, she was treated with cognitive-
behavioral therapy (CBT) for 10 months with poor outcome. 
Then, CBT was associated with sertraline (150 mg/daily). After 
3 months, the level of anxiety on CBT exposures lowered. She 
started to shout when playing handball, she talks louder to 
her mother in public places, and talks to friends through lips 
movements. Though she isn’t talking to many people yet, she 
is clearly less anxious.
There is some controversy whether SM is an anxiety disorder 
(AD) or an independent diagnosis. Previously, SM was considered 
an oppositional behavior, a psychotic symptom or a dissociative 
disorder. In DSM-IV, SM is classified under Other Disorders of 
Childhood. SM has many aspects in common with AD: pre-
morbid temperament (shyness, behavioral inhibition), parent-child 
overdependence, overlapping diagnoses with other AD (social 
phobia, separation anxiety), and high prevalence of parents with 
AD.5 Some authors propose that SM is an extreme manifestation 
of social phobia.2 Our patient denied having social anxiety in 
situations that don’t involve talking, but other anxiety symptoms 
were observed, such as early manifestation of separation anxiety, 
supporting the hypothesis that SM should be considered an anxiety 
spectrum disorder.
Although genetic, behavioral, psychodynamic and family factors 
must be considered, the etiology of SM remains unknown.1 The 
available options for clinical treatment are based on open-label 
studies, case reports and clinical experience.3,5 This case has 
shown a better outcome when biological and psychotherapy 
interventions were associated, which may indicate a field for 
future researches. Having SM as a subcategory of AD may benefit 
its comprehension, not only as a symptom, but as a unique 
disorder with its own characteristics. 
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Dear Editor,
Recently, we have published a case report describing a patient 
with history of maniac behavior that started three weeks after a 
right medial frontal lobe stroke that was successfully managed 
with valproic acid.1
Our Department of Psychiatry has evaluated a second case 
with poststroke hypomania symptoms. 
A 57-year-old Caucasian man, married, salesman, with a 
15-year history of hypertension and diabetes was admitted to 
our ward with occasional episodes (six per month) of irritability, 
emotional labiality, reduced sleep need, rapid speech and 
thoughts. Each episode lasted for two days approximately. These 
symptoms had begun after a severe case of stroke affecting 
his right temporal-parietal lobe with unspecific lesions in the 
white matter in both hemispheres eights months before the 
admission. Magnetic resonance scan was carried out soon after 
the stroke and showed an area at the right temporal-parietal 
lobe compatible with stroke and few chronic ischemic lesions 
widespread throughout the white matter (Figure 1).
Although he did not fulfilled clinical criteria for manic episode 
according to DSM-IV-TR, his Young Mania Rating Scale (YMRS) 
classification was 21 (range 0-20) during one of the episodes. 
No previous history of any psychiatric disorder, including mood 
or substance use disorders, could be evidenced.
A neurological examination was performed whereas he scored 
28 out of 30 in the Folstein Mini-Mental State Examination. No 
cognitive deficits were observed.
Laboratory work-up, including complete blood count, creatine 
kinase level, electrolytes, renal, liver and thyroid function tests, 
serology for syphilis and HIV were unrevealing. 
Valproic acid (750 mg/day) was init iated with good 
improvement of his symptoms (YMRS scoring 10 during “mood 
episodes”; serum level of valproic acid was 79.0 µg/ml).
Discussion: Some papers discuss a probable correlation 
between mania episodes after right hemisphere lesions, mainly 
in right orbitofrontal and basotemporal cortices, the dorsomedial 
thalamic nucleus and the head of the caudate nucleus.1-3
In our patients, both presented symptoms of mania after a 
stroke that affected the right portion of the brain. Despite the 
two cases, classic poststroke mania syndrome is not frequently 
observed, and the major hypothesis for this is that it takes more 
than one area with a dysfunction to make this occur. Also, an 
increase in serotonin receptor binding on the right hemisphere, 
caused by stroke event, may explain why mania episodes are 
always related to injuries on the right lobe of the brain.1,3
It has also been discussed a connection between the white 
matter hyperintensities (WMH) lesions in poststroke mania 
cases, including our cases. These could be a result from vascular 
cerebral tissue insults and there is also accumulated evidence 
supporting a role of WMH in the pathophysiology of adult-onset 
bipolar disorder.4
There are some drugs used for the treatment of this condition, 
like olanzapine, lithium, carbamazepine and valproic acid. In 
both our cases, the last one had the most successful result. 
Perhaps, mood stabilizing anticonvulsants may be the agents 
of choice in the treatment of secondary mania, besides the 
propensity for seizures in the poststroke period.1-3
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